Lee Horobin - TBG Diagnostics Insider

PGL -- Australia Stock  

null 0.16  0.00  0.00%

General Manager of Fin.
Mr. Lee Horobin serves as General Manager Finance of Progen Pharmaceuticals Limited since August 23 2012. He served as Company Secretary from March 1 2010 to May 24 2010 and Acting General Manager Finance from March 1 2010 to May 2010. He has commenced with Progen on an interim basis due to an extended period of absence of Mr. Paul Dixon
  Executive Since 2012  CPA    
61 7 3273 9133  http://www.tbgbio.com
Horobin is a member of CPA Australia and has held company secretarial positions in previous roles.

Management Efficiency

The company has return on total asset (ROA) of (47.62) % which means that it has lost $47.62 on every $100 spent on asset. This is way below average.

Similar Executives

Showing few of many executives

EXECUTIVE Since

David WhiteingCommonwealth Bank of Australia
2014
David CurranWestpac Banking Corporation
2014
John LevyCSL Limited
2017
Bold BaatarRio Tinto Limited
2016
Michael UtslerWoodside Petroleum Ltd
2016
Arnaud SoiratRio Tinto Limited
2016
Sue JohnsonTransurban Group
2012
Maya DriesenWesfarmers Limited
2015
Andrew HardingRio Tinto Limited
2013
Fred OhlssonAustralia and New Zealand Banki
2016
Clare McManusCommonwealth Bank of Australia
2017
Alfredo BarriosRio Tinto Limited
2014
Bernard RonchiCSL Limited
2015
Linda KenyonWesfarmers Limited
2002
Julie GalliganTransurban Group
2012
Kara NichollsWoolworths Group Limited
2015
Alan CarpenterWesfarmers Limited
2009
Adrian WentAustralia and New Zealand Banki
2018
David LindbergWestpac Banking Corporation
2015
Simone NivenRio Tinto Limited
2017
Alden ToevsCommonwealth Bank of Australia
2008

Entity Summary

TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. TBG Diagnostics Limited (PGL) is traded on Australian Securities Exchange in Australia. It is located in Darra, QLD and employs 10 people.

TBG Diagnostics Limited Leadership Team

Fleur Lankesheer, Director
Keith Dredge, Director, Ph.D
Leslie Tillack, CEO
YuZen Cheng, Director
ChiaChuan Chang, Director
Lee Horobin, Executive, CPA
ShiChung Chang, Director, Ph.D
Indrajit Arulampalam, Chairman
Blair Lucas, Executive
Emily Lee, Director

Stock Performance Indicators

Current Sentiment - PGL

TBG Diagnostics Limited Investor Sentiment
Macroaxis portfolio users are evenly split in their perspective on investing in TBG Diagnostics Limited. What is your outlook on investing in TBG Diagnostics Limited? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip
Currently Active Assets on Macroaxis
BND   
Purchased few shares of
few hours ago
Traded for 79.19
QQQ   
Purchased few shares of
few hours ago
Traded for 179.93
SPY   
Purchased few shares of
few hours ago
Traded for 281.04
TRP   
Sold one share of
few hours ago
Traded for 42.84
KO   
Purchased over 90 shares of
few hours ago
Traded for 45.12
Additionally take a look at Your Equity Center. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.